Detalle de: Viral non-coding RNAs as antivirals
| Title | Viral non-coding RNAs as antivirals |
| Description |
Structural domains of the FMDV 5' and 3' non-coding regions and their RNA-RNA and RNA-protein interactions, and the biotherapeutic use of synthetic non-coding RNAs derived from them: broad-spectrum antiviral activity against zoonotic viruses (FMDV, West Nile, Rift Valley fever and African swine fever viruses) and SARS-CoV-2, enhancement of vaccine responses, and nanotechnology-based delivery formulations. |
| Research Groups | Modulation of antiviral immunity by viral proteases and noncoding RNAs |
| Researchers | Miryam Polo Hernández |
